NANOG and breast carcinoma: It has been reported that hyaluronan–CD44 interactions are capable of stimulating ABCB1 expression and activity through promoting ankyrin–cytoskeleton interactions, Nanog-Stat-3 signalling, ErbB2 signalling and PI3K/AKT-related survival pathways in breast cancer cell lines [121].